BACKGROUND Over the last two decades, significant research interest has led to the development of a wide variety of supraglottic airways (SGAs) for anaesthesia providers to choose from. METHODS In this network meta-analysis, we analysed 111 studies, enrolling 12 045 patients undergoing airway management with 29 SGAs. We targeted outcomes that contribute to clinicians' choice of one SGA over another. The primary outcome was the incidence of postoperative sore throat (POST). Secondary outcomes were first-attempt insertion success, bleeding complications, and oropharyngeal leak pressure (OLP). Based on credible intervals, we created a 'rank order' to guide decision-making for clinicians. RESULTS The highest-ranking devices based on credible intervals for POST, bleeding complications, first-attempt insertion success, and OLP were LMA Ambu, Jcerity Endoscoper, LMA Blockbuster, and LMA Baska Mask, respectively. Air-Q and i-gel ranked favourably across multiple outcomes, with i-gel being the only device to rank within the top six SGAs for POST, bleeding, and first-attempt success despite ranking poorly for OLP. CONCLUSIONS Our data support the use of LMA-Ambu, Jcerity-Endoscoper, Air-Q, and i-gel when considering patient-centred outcomes. Clinician familiarity with these devices and their continued expansion into anaesthetic practice will have important implications on the perioperative patient experience. SYSTEMATIC REVIEW PROTOCOL PROSPERO (CRD42022383136).

中文翻译：

---

声门上气道装置的选择：随机对照试验的网络荟萃分析。


背景在过去的二十年里，巨大的研究兴趣导致了各种各样的声门上气道 （SGA） 的开发，供麻醉提供者选择。方法 在本网络荟萃分析中，我们分析了 111 项研究，招募了 12 045 名接受气道管理的患者，其中 29 名 SGA。我们针对有助于临床医生选择一种 SGA 而不是另一种的结局。主要结局是术后喉咙痛 （POST） 的发生率。次要结局是首次尝试插入成功、出血并发症和口咽渗漏压 （OLP）。根据可信的区间，我们创建了一个 “排名顺序” 来指导临床医生的决策。结果 基于 POST 、出血并发症、首次尝试插入成功和 OLP 的可信间隔排名最高的设备分别为 LMA Ambu、Jcerity Endoscoper、LMA Blockbuster 和 LMA Baska Mask。Air-Q 和 i-gel 在多个结果中排名靠前，i-gel 是唯一在 POST 、出血和首次尝试成功率方面排名前六名的设备，尽管 OLP 排名很差。结论 在考虑以患者为中心的结局时，我们的数据支持使用 LMA-Ambu 、 Jcerity-Endoscoper 、 Air-Q 和 i-gel。临床医生对这些设备的熟悉程度以及它们对麻醉实践的持续扩展将对围手术期患者体验产生重要影响。系统评价 PROTOCOL PROSPERO （CRD42022383136）。